Klin Padiatr 2019; 231(03): 166
DOI: 10.1055/s-0039-1687165
Georg Thieme Verlag KG Stuttgart · New York
Genome-wide CRISPR screen in patient derived cells reveals the mechanism of ALL chemoresistance
K Szoltysek
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
K Dormon
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
H Blair
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
R Tirtakusuma
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
C Dodd
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
E Law
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
S Nakjang
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
D Pal
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
,
J Vormoor
2
Princess Maxima Center for Pediatric Oncology, Utrecht 3584CS, the Netherlands
,
O Heidenreich
1
Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
› Institutsangaben
